SYMBICORT Medication Guide
medications, including the differences in prescribed use and physical appearance. ... • Store SYMBICORT at room temperature between 68°F to 77°F (20°C to 25°C). ... Storage above 120ºF may cause the canister to burst. • Throw away SYMBICORT when the counter reaches zero (“0”) or 3 months after you take SYMBICORT out of its foil ...
Download SYMBICORT Medication Guide
Information
Domain:
Source:
Link to this page:
Documents from same domain
Imfinzi Full Prescribing Information
den8dhaj6zs0e.cloudfront.netlung cancer (NSCLC) whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy. (1.1) • in combination with etoposide and either carboplatin or cisplatin, as first-line treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC). (1.2)
Lynparza Prescribing Information
den8dhaj6zs0e.cloudfront.net5.4 Venous Thromboembolic Events 6 ADVERSE REACTIONS 6.1 Clinical Trial Experience 6.2 Postmarketing Experience 7 DRUG INTERACTIONS 7.1 Use with Anticancer Agents 7.2 Effect of Other Drugs on Lynparza 8 USE IN SPECIFIC POPULATIONS 8.1 Pregnancy 8.2 Lactation 8.3 Females and Males of Reproductive Potential 8.5 Geriatric Use 8.6 Renal Impairment
BREZTRI Full Prescribing Information
den8dhaj6zs0e.cloudfront.netIf the inhaler has not been used for more than 7 days, is dropped, or after weekly . cleaning, prime the inhaler again by releasing 2 sprays into the air away from the face, shaking well before each spray. 2.3 Dose counter. BREZTRI AEROSPHERE canister has an attached dose indicator, which indicates . how many inhalations remain.
SYMBICORT Prescribing Information
den8dhaj6zs0e.cloudfront.net5.18 Hypokalemia and Hyperglycemia. 6 ADVERSE REACTIONS. 6.1 Clinical Trials Experience in Asthma 6.2 Clinical Trials Experience in Chronic Obstructive Pulmonary Disease. 6.3 Postmarketing Experience. 7 DRUG INTERACTIONS. Antidepressants 7.3 Beta-Adrenergic Receptor Blocking Agents 7.4 Diuretics. 8 USE IN SPECIFIC POPULATIONS. 8.1 Pregnancy …
US-56427 ---------------------------- DOSAGE AND ...
den8dhaj6zs0e.cloudfront.netnot start BRILINTA in patients undergoing urgent coronary artery bypass graft surgery (CABG). (5.1, 6.1) • If: possible, manage bleeding without discontinuing ----- BRILINTA. Stopping BRILINTA increases the risk of subsequent cardiovascular events. (5.4) ASPIRIN DOSE AND BRILINTA EFFECTIVENESS IN PATIENTS WITH ACS ...
Farxiga Prescribing Information
den8dhaj6zs0e.cloudfront.netpatients with polycystic kidney disease or patients requiring or with a recent . history of immunosuppressive therapy for the treatment of kidney disease. FARXIGA is not expected to be effective in these populations. (1)----- DOSAGE AND ADMINISTRATION ----- • Assess volume status and correct volume depletion before initiating. ...
FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE ...
den8dhaj6zs0e.cloudfront.netHealthcare Providers for detail on preparation and administration. (2) ... registered nurses, and physician assistants that are licensed or authorized under state law to prescribe drugs in the therapeutic class to which EVUSHELD belongs (i.e., anti-infectives).
CRESTOR PRESCRIBING INFORMATION
den8dhaj6zs0e.cloudfront.netreduce elevated total-C, LDL-C, ApoB, nonHDL-C, and TG levels and to increase HDL-C (1.1) ... Monitor INR frequently until stable upon initiation or alteration of CRESTOR therapy. (5.4, 7.6) • Concomitant lipid-lowering therapies: Use with fibrates or lipid-modifying doses (≥1 g/day)
Saphnelo full Prescribing Information
den8dhaj6zs0e.cloudfront.netwith severe active lupus nephritis or severe active central nervous system lupus. Use . of SAPHNELO is not recommended in these situations. (1)----- DOSAGE AND ADMINISTRATION -----The recommended dosage is 300 mg as an intravenous infusion over a 30-minute . …
CALQUENCE PRESCRIBING INFORMATION
den8dhaj6zs0e.cloudfront.netTable 1: Recommended Dose Modifications for Use with CYP3A Inhibitors or Inducers CYP3A Co-administered Drug Recommended CALQUENCE use Inhibition Strong CYP3A inhibitor Avoid concomitant use. If these inhibitors will be used short-term (such as anti-infectives for up to seven days), interrupt CALQUENCE. Moderate CYP3A inhibitor 100 mg once daily.
Related documents
Standing Order for REGEN-COV (casirivimab and imdevimab ...
health.mo.govto 8 ºC (36 ºF to 46 ºF) for no more than 4 hours or at room temperature up to 25 ºC (77 ºF) for no more than 4 total hours. If refrigerated, allow the syringes to equilibrate to room temperature for approximately 20 minutes prior to administration. Basic Equipment Equipment requirements may vary by medical direction.
TYPE 2 DIABETES ADULT OUTPATIENT INSULIN GUIDELINES
med.stanford.eduStorage2,5 Refrigerate insulin until opened. Discard after expiration date. Once opened can be kept at room temperature. Avoid heat. Replace insulin vial or pen as required per specific insulin package insert. Syringes and Needles For pen consider use pen needles that are 31or 32 gauge and 5 mm to 8 mm. For vials consider use syringes that are ...
MEDICATIONS GUIDE - California
www.ccld.dss.ca.govmedications prescribed during an illness determined by the physician to be temporary and ... The guidelines for the proper storage, security, and documentation of centrally stored medications. ... refrigerate, room temperature, out of
SELF-ASSESSMENT GUIDE
www.ccld.dss.ca.govprescription medications for each resident, which includes the information specified in subsections (h)(6)(A) through (F), is maintained for at least one year (22 CCR 87465(h)(6)). The licensee shall, and staff designated by the licensee may, assist residents with self-administered medications as needed (22 CCR 87465(a)(5) and (6)).
COVID-19 Vaccine Handling Toolkit Transporting COVID-19 ...
www.usp.orgMay 11, 2021 · other medications, when not under supervision of healthcare personnel. ... Ambient room temperature at 8°C to 25°C (46°F to 77°F) 12 hours ... * If the storage temperature is changed to an unmonitored temperature container, …